Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Systemic lupus erythematosus
(
SLE
) is an autoimmune disease with unknown etiology, characterized by the presence of auto-antibodies to various cellular components and chronic inflammation of different organ systems. A number of susceptibility loci for
SLE
have been suggested in different populations, but the nature of the susceptibility genes and mutations is yet to be identified. The programmed cell death 1 gene (PDCD1) was considered to be one of the strongest candidate genes associated with
SLE
. Here, we analyzed 265 individuals for single-nucleotide polymorphisms (SNPs) in PDCD1, including 122 unrelated individuals affected with
SLE
and 143 random healthy volunteer individuals in Han Chinese. Genomic DNA was prepared from peripheral blood leukocytes and the SNPs were further confirmed by DNA sequencing. We found there were statistically significant differences in the distribution of genotypes at 7872 locus (OR = 0.59, 95%CI = 0.41-0.85) and 8162 locus (OR = 0.54, 95%CI = 0.37-0.78) between
SLE
and control. Genotype TT in 7872 locus (OR = 0.58, 95%CI = 0.34-1.00) and GG genotype in 8162 locus (OR = 0.46, 95%CI = 0.26-0.80) might be protective for
SLE
prevention. The associated SNPs might regulate the binding of some transcription factors, such as AML-1a, USF and
MZF-1
, suggesting a mechanism through which it can contribute to the predisposition of
SLE
.
...
PMID:Programmed cell death 1 genotypes are associated with susceptibility to systemic lupus erythematosus among Chinese. 1799 73